Cargando…
Suppression of nitric oxide production from nasal fibroblasts by metabolized clarithromycin in vitro
BACKGROUND: Low-dose and long-term administration of 14-membered macrolide antibiotics, so called macrolide therapy, has been reported to favorably modify the clinical conditions of chronic airway diseases. Since there is growing evidence that macrolide antibiotic-resistant bacteria's spreaders...
Autores principales: | Furuya, Ayako, Asano, Kazuhito, Shoji, Naruo, Hirano, Kojiro, Hamasaki, Taisuke, Suzaki, Harumi |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3003651/ https://www.ncbi.nlm.nih.gov/pubmed/21092318 http://dx.doi.org/10.1186/1476-9255-7-56 |
Ejemplares similares
-
Tiotropium bromide inhibits TGF-β-induced MMP production from lung fibroblasts by interfering with Smad and MAPK pathways in vitro
por: Asano, Kazuhito, et al.
Publicado: (2010) -
Suppression of IL-8 production from airway cells by tiotropium bromide in vitro
por: Suzaki, Isao, et al.
Publicado: (2011) -
Suppression of Matrix Metalloproteinase Production in Nasal
Fibroblasts by Tranilast, an Antiallergic Agent, In Vitro
por: Shimizu, Toshiyuki, et al.
Publicado: (2005) -
Suppression of Osteopontin Functions by Levocetirizine, a Histamine H(1) Receptor Antagonist, In Vitro
por: Komatsuzaki, Toshimitsu, et al.
Publicado: (2013) -
Suppressive activity of macrolide antibiotics on nitric oxide production by lipopolysaccharide stimulation in mice.
por: Terao, Hajime, et al.
Publicado: (2003)